BMRA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Biomerica Inc (BMRA) is not a strong buy for a beginner investor with a long-term strategy at this moment. The lack of positive financial performance, no significant trading trends, and absence of strong technical or proprietary trading signals suggest holding off on investing in this stock currently.
The MACD is slightly positive but contracting, RSI is neutral at 48.106, and moving averages are converging, indicating no strong trend. The stock is trading near its pivot level of 2.132, with resistance at 2.205 and support at 2.06. Overall, the technical indicators do not suggest a strong buy signal.
NULL identified. No recent news, no significant insider or hedge fund activity, and no proprietary trading signals.
Financials show declining revenue (-11.80% YoY), negative gross margin (-4.46%), and a drop in EPS (-8.33% YoY). Additionally, there is no recent congress trading data or influential figure activity.
In 2026/Q3, revenue dropped to $987,000 (-11.80% YoY), net income improved slightly to -$1,312,000 (+12.81% YoY), EPS dropped to -0.44 (-8.33% YoY), and gross margin significantly declined to -4.46% (-362.35% YoY). The financials indicate a struggling company with no clear growth trends.
No analyst rating or price target changes available for BMRA.
